Sitagliptin DeaMino IMpurity 1
|
|
|
- CAS-Nr.
- 1253056-18-6
- Englisch Name:
- Sitagliptin DeaMino IMpurity 1
- Synonyma:
- Sitagliptin FP Impurity D;Impurity FP-D;Sitagliptin iMpurity S;Sitagliptin Impurity 01;Sitagliptin Impurity 05;Sitagliptin Impurity FP-D;Sitagliptin Impurities 05;Sitagliptin EP Impurity 13;Sitagliptin EP Impurity FP-D;Sitagliptin DeaMino IMpurity 1
- CBNumber:
- CB22675695
- Summenformel:
- C16H12F6N4O
- Molgewicht:
- 390.28
- MOL-Datei:
- 1253056-18-6.mol
|
Sitagliptin DeaMino IMpurity 1 Eigenschaften
- Siedepunkt:
- 517.5±60.0 °C(Predicted)
- Dichte
- 1.52±0.1 g/cm3(Predicted)
- storage temp.
- Hygroscopic, -20°C Freezer, Under inert atmosphere
- L?slichkeit
- DMSO (Slightly), Methanol
- pka
- -0.06±0.20(Predicted)
- Aggregatzustand
- Solid
- Farbe
- Colourless to Pale Yellow Gel to Waxy
- Stabilit?t:
- Hygroscopic
- Major Application
- pharmaceutical small molecule
- InChI
- InChI=1S/C16H12F6N4O/c17-10-7-12(19)11(18)6-9(10)2-1-3-14(27)25-4-5-26-13(8-25)23-24-15(26)16(20,21)22/h1,3,6-7H,2,4-5,8H2/b3-1+
- InChIKey
- QSSHJJFVCWMIKH-HNQUOIGGSA-N
- SMILES
- C(N1CCN2C(C(F)(F)F)=NN=C2C1)(=O)/C=C/CC1=CC(F)=C(F)C=C1F
Sitagliptin DeaMino IMpurity 1 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
3-Desamino-2,3-dehydro Sitagliptin is an impurity of Sitagliptin (S491000); a trizolopyrazine dipeptidyl peptidase IV inhibitor. Sitagliptin has recently been approved for the therapy of type II diabetes.
Sitagliptin DeaMino IMpurity 1 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Sitagliptin DeaMino IMpurity 1 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 96)Lieferanten
1253056-18-6()Verwandte Suche:
- Sitagliptin DeaMino IMpurity 1
- (2E)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one
- (E)-1-(3-(trifluoroMethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one
- Sitagliptin iMpurity S
- (E)-1-(3-(trifluoromethyl)-5,6-dihydro
- Sitagliptin impurity 8/Sitagliptin FP Impurity D/3-Desamino-2,3-Dehydro Sitagliptin/(2E)-1-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one
- 3-Desamino-2,3-dehydro Sitagliptin
- Sitagliptin Impurity FP-D
- Sitagliptin phenyl crotonyl analog
- Impurity FP-D
- Sitagliptin EP Impurity FP-D
- Sitagliptin USPPhenylcrotonyl Analog
- 2-Buten-1-one, 1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (2E)-
- Sitagliptin EP Impurity 13
- Sitagliptin Impurity 01
- (E)-1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one (Sitagliptin Impurity)
- Sitagliptin Steryl acetyl Analog
- SITAGLIPTIN STYRYLACETYL IMPURITY
- Sitagliptin Phenylcrotonyl Analog (Sitagliptin FP Impurity D/ 3-Desamino-2,3-Dehydro Sitagliptin)
- Sitagliptin Phenylcrotonyl Analog/Sitagliptin FP Impurity D
- Sitagliptin Tablets EP Impurity FP-D
- Sitagliptin FP Impurity D
- Sitagliptin Impurity 17 (Sitagliptin Tablets EP Impurity FP-D)
- Sitagliptin Impurity 05
- (2E)-1-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one
- Sitagliptin FP Impurity D / Sitagliptin Phenylcrotonyl Analog (USP)
- Sitagliptin Phosphate Impurity 17 (Sitagliptin Tablets EP Impurity FP-D)
- Sitagliptin Impurities 05
- 1253056-18-6
